EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites

Barbara Forte iD, Fiona Bellany, Peter S Campbell, Giulia Chemi iD, Alice Dawson iD, Mark Anderson, Yaw Aniweh iD, Anna Y Burkhard, Anna Caroline Campos Aguiar iD, Alisje Churchyard, Caitlin A Cooper, Amália Dos Santos Ferreira und 48 weitere

Journal of Medicinal Chemistry · 11.06.2026 · 69 (11) · 13820-13855

DOI: 10.1021/acs.jmedchem.6c00823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 02.06.2026. Verfasst von Barbara Forte und 59 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. Hauptthemen laut MEDLINE: Antimalarials, Lysine-tRNA Ligase, Plasmodium falciparum, Enzyme Inhibitors. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A fused dihydropyrrolidino-pyrimidine hit with low lipophilicity and excellent ligand efficiency was identified in a biochemical screen of the Global Health Chemical Diversity Library (GHCDL) against Plasmodium lysyl-tRNA synthetase (KRS). Structure-guided lead optimization delivered analogues with potent parasite growth inhibition, excellent biochemical and cellular selectivity (>1000-fold), and oral efficacy in the malaria NOD-scid-IL2Rγnull (SCID) mouse model. Structural information and computational methods were deployed to identify a potent and selective basic KRS inhibitor (30) with an extended half-life to reduce the dose regimen to a single-dose cure. Compound 30 displayed a long half-life across preclinical species, favorable safety, and activity across Plasmodium species as well as against drug-resistant and sensitive P. falciparum strains and field isolates. Unfortunately, 30 lacked oral bioavailability, which could not be mitigated with a prodrug approach. Nevertheless, learnings from this series will assist future KRS programs in delivering a clinical candidate with this novel mode of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsLysine-tRNA LigasePlasmodium falciparumEnzyme InhibitorsPyrimidinesPlasmodiumAnimalsStructure-Activity RelationshipHumansMiceMalariaMice, SCID

Substanzen

AntimalarialsLysine-tRNA LigaseEnzyme InhibitorsPyrimidines

Autor:innen und Institutionen

  • Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
  • West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Accra LG54, Ghana.
  • Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Department of Microbiology, Immunology, and Parasitology, Federal University of São Paulo, São Paulo, São Paulo CEP 04023-062, Brazil.
  • Department of Life Sciences, Imperial College, London SW7 2AZ, U.K.

ORCID-Profile: Barbara Forte, Giulia Chemi, Alice Dawson, Yaw Aniweh, Anna Caroline Campos Aguiar, Mufuliat Toyin Famodimu, Delphine Baud, Benigno Crespo-Fernández, Sachel Mok, Anne-Catrin Uhlemann, Rafael Victorio Carvalho Guido, Michael J Delves, Laurent Dembele, Francisco Javier Gamo

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Bill and Melinda Gates Foundation
  • Medicines for Malaria Venture
  • Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo
  • National Institutes of Health
  • National Research Foundation
  • Global Health Innovative Technology Fund

Zitieren

APA

Forte, B., Bellany, F., Campbell, P. S., Chemi, G., Dawson, A., Anderson, M., Aniweh, Y., Burkhard, A. Y., Aguiar, A. C. C., Churchyard, A., Cooper, C. A., Dos Santos Ferreira, A., Famodimu, M. T., Fang, F. G., Hu, X., Huijs, T., Baud, D., Jansen, C., Jiménez Díaz, M. B., …, & Gamo, F. J. (2026). Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites. Journal of Medicinal Chemistry, 69(11), 13820-13855. https://doi.org/10.1021/acs.jmedchem.6c00823

Vancouver

Forte B, Bellany F, Campbell PS, Chemi G, Dawson A, Anderson M, et al. Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites. Journal of Medicinal Chemistry. 2026;69(11):13820-13855. doi:10.1021/acs.jmedchem.6c00823

BibTeX
@article{Forte2026,
  author = {Forte, Barbara and Bellany, Fiona and Campbell, Peter S and Chemi, Giulia and Dawson, Alice and Anderson, Mark and Aniweh, Yaw and Burkhard, Anna Y and Aguiar, Anna Caroline Campos and Churchyard, Alisje and Cooper, Caitlin A and Dos Santos Ferreira, Amália and Famodimu, Mufuliat Toyin and Fang, Francis G and Hu, Xiao and Huijs, Tonnie and Baud, Delphine and Jansen, Chimed and Jiménez Díaz, María Belén and Bonnert, Roger and Boyd, Susan and Crespo-Fernández, Benigno and Mitasev, Branko and Montagna, Simone and Mok, Sachel and Murugesan, Dinakaran and Narwal, Sunil K and Norcross, Neil R and Okombo, John and Park, Heekuk and Peet, Caroline and Pereira, Dhelio B and Post, John M and Reader, Janette and Riley, Jennifer and Robinson, David A and Shinkyo, Raku and Simeons, Frederick R C and Simpson, Laura and Smith, Alasdair and Smith, Dennis and Striepen, Josefine and Teles, Carolina B G and van der Laak, Rianne and Uhlemann, Anne-Catrin and Vantaux, Amélie and Wilson, Caroline and Witkowski, Benoît and Wood, Gavin and Yeo, Tomas and Zuccotto, Fabio and Angulo-Barturen, Iñigo and Baum, Jake and Bolscher, Judith M and Guido, Rafael Victorio Carvalho and Birkholtz, Lyn-Marié and Delves, Michael J and Dembele, Laurent and Fidock, David A and Gamo, Francisco Javier},
  title = {Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {11},
  pages = {13820--13855},
  doi = {10.1021/acs.jmedchem.6c00823}
}
Kostenlos starten →